ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,674, issued on Aug. 19, was assigned to OTSUKA PHARMACEUTICAL Co. LTD. (Tokyo).
"Heterocyclic compounds for the treatment of epilepsy" was invented by Tomoichi Shinohara (Osaka, Japan), Shin Iwata (Osaka, Japan), Masaki Suzuki (Osaka, Japan), Kenta Arai (Osaka, Japan), Nobuaki Ito (Osaka, Japan) and Takuya Chiba (Osaka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel heterocyclic compound represented by Formula [I] and a salt thereof:wherein the symbols are as defined in the specification, which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure...